Ronald W. Clark

3.4k total citations · 2 hit papers
51 papers, 2.1k citations indexed

About

Ronald W. Clark is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ronald W. Clark has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 8 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ronald W. Clark's work include Lipoproteins and Cardiovascular Health (9 papers), Cholesterol and Lipid Metabolism (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Ronald W. Clark is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Cholesterol and Lipid Metabolism (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Ronald W. Clark collaborates with scholars based in United States. Ronald W. Clark's co-authors include M J Bamberger, Margaret E. Brousseau, J. L. Heilbron, Andrés Digenio, James P. Mancuso, Daniel J. Rader, LeAnne T. Bloedon, Ernst J. Schaefer, Megan L. Wolfe and Roger B. Ruggeri and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Ronald W. Clark

45 papers receiving 2.0k citations

Hit Papers

Effects of an Inhibitor of Cholesteryl Ester Transfer Pro... 2004 2026 2011 2018 2004 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
    2004 574 citations Margaret E. Brousseau, Ernst J. Schaefer et al. New England Journal of Medicine profile →
  2. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
    2016 406 citations Saswata Talukdar, Yingjiang Zhou et al. Cell Metabolism profile →

Peers

Ronald W. Clark
Can Bruce United States
David Rubinstein United States
Claudia Großmann Germany
R. Dermot G. Neely United Kingdom
Michael P. Caulfield United States
Dov Shiffman United States
G. Martin Benson United Kingdom
Mary E. Haas United States
Masood N. Khan Canada
Lara M. Mangravite United States
Can Bruce United States
Ronald W. Clark
Citations per year, relative to Ronald W. Clark Ronald W. Clark (= 1×) peers Can Bruce

Countries citing papers authored by Ronald W. Clark

Since Specialization
Citations

This map shows the geographic impact of Ronald W. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald W. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald W. Clark more than expected).

Fields of papers citing papers by Ronald W. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald W. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald W. Clark. The network helps show where Ronald W. Clark may publish in the future.

Co-authorship network of co-authors of Ronald W. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald W. Clark. A scholar is included among the top collaborators of Ronald W. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald W. Clark. Ronald W. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talukdar, Saswata, Yingjiang Zhou, Dongmei Li, et al.. (2016). A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. Cell Metabolism. 23(3). 427–440. 406 indexed citations breakdown →
2.
Clark, Ronald W., Nicholas B. Vera, Kou Kou, et al.. (2015). Characterization of a Novel Intestinal Glycerol-3-phosphate Acyltransferase Pathway and Its Role in Lipid Homeostasis. Journal of Biological Chemistry. 291(6). 2602–2615. 29 indexed citations
3.
Kalgutkar, Amit S., Kosea S. Frederick, Heather L. Hatch, et al.. (2013). Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility. Xenobiotica. 44(7). 591–605. 2 indexed citations
4.
Liu, Shenping, Anil Mistry, Jennifer M. Reynolds, et al.. (2012). Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors. Journal of Biological Chemistry. 287(44). 37321–37329. 61 indexed citations
5.
Clark, Ronald W., David Cunningham, Cong Yang, et al.. (2009). Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection. Journal of Lipid Research. 51(5). 967–974. 21 indexed citations
6.
Wołk, Robert, et al.. (2009). Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects. Clinical Pharmacology & Therapeutics. 86(4). 430–437. 9 indexed citations
7.
Clark, Ronald W.. (2006). Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors. Current Opinion in Pharmacology. 6(2). 162–168. 21 indexed citations
8.
Clark, Ronald W., Roger B. Ruggeri, David Cunningham, & M J Bamberger. (2005). Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action. Journal of Lipid Research. 47(3). 537–552. 113 indexed citations
9.
Brousseau, Margaret E., Ernst J. Schaefer, Megan L. Wolfe, et al.. (2004). Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol. New England Journal of Medicine. 350(15). 1505–1515. 574 indexed citations breakdown →
10.
Gaynor, Brady, et al.. (1994). Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition. Atherosclerosis. 110(1). 101–109. 39 indexed citations
11.
Clark, Ronald W. & Richard C. Crain. (1986). Characterization of alterations in plasma lipoprotein lipid and apoprotein profiles accompanying hepatoma-induced hyperlipidemia in rats.. PubMed. 46(4 Pt 2). 1894–903. 22 indexed citations
12.
Clark, Ronald W.. (1985). Sigmund Freud : Leben und Werk. Fischer Taschenbuch eBooks. 1 indexed citations
13.
Clark, Ronald W.. (1984). Einstein : the life and times : an illustrated biography. 1 indexed citations
14.
Clark, Ronald W.. (1980). Freud, the man and the cause. 57 indexed citations
15.
Clark, Ronald W.. (1979). Albert Einstein : Leben und Werk. CERN Document Server (European Organization for Nuclear Research). 3 indexed citations
16.
Clark, Ronald W.. (1976). Semblanza de Sir Julián Huxley. Revista de occidente. 58–66. 1 indexed citations
17.
Clark, Ronald W., et al.. (1974). Albert Einstein. Leben und Werk. Eine Biographie.. 1 indexed citations
18.
Clark, Ronald W.. (1961). The birth of the bomb : the untold story of Britain's part in the weapon that changed the world. 5 indexed citations
19.
Clark, Ronald W.. (1960). Sir Mortimer Wheeler. 2 indexed citations
20.
Clark, Ronald W.. (1953). The Victorian mountaineers. Medical Entomology and Zoology. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Can Bruce Breakdown of academic impact, for papers by David Rubinstein Breakdown of academic impact, for papers by Claudia Großmann Breakdown of academic impact, for papers by R. Dermot G. Neely Breakdown of academic impact, for papers by Michael P. Caulfield Breakdown of academic impact, for papers by Dov Shiffman Breakdown of academic impact, for papers by G. Martin Benson Breakdown of academic impact, for papers by Mary E. Haas Breakdown of academic impact, for papers by Masood N. Khan Breakdown of academic impact, for papers by Lara M. Mangravite
Rankless by CCL
2026